ibitasony.wordpress.com
Cephalon, Inc. is an internationa l biopharmaceutical company dedicated to the development and commercialization of innovative products in thred coretherapeutic areas: central nervous systej ("CNS"), pain and oncology. In addition to conductin an active research anddevelopment program, we markeg seven proprietary products in the United Stateas and numerous products in variouz countries throughout Europe and the Consistent with our core therapeutic areas, we have alignesd our approximately 780-person U.S.
field salexs and sales management teams by We have a sales and marketinb organization numbering approximately 400 persons that supportsw our presence in nearly 20 European including France, the United Kingdom, Germany, Italy and and certain countries in Africa and the Middlw East. For the year ended December 31, 2008, our totall revenues and net incomeswere $2.0 billion and $222.5 million, respectively. Our revenueds from U.S. and European operations are detailed in Note 18 to our Consolidatexd Financial Statements included inPart II, Item 8 of this Annuaol Report on Form 10-K.
Our most significant productt isPROVIGIL
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment